September 24, 2022 article Open access Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) Journal of Affective Disorders DOI: 10.1016/j.jad.2022.09.043 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 144 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response 2026 BMC Psychiatry article Medicine Treatment of Major Depression Open access 2 citations Intranasal esketamine significantly alleviates depression severity and suicidal ideations in electroconvulsive therapy (ECT) non-responders 2025 European Archives of Psychiatry and Clinical Neuroscience article Medicine Treatment of Major Depression Open access 3 citations Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study 2022 Frontiers in Psychiatry article Medicine Treatment of Major Depression Open access 43 citations 3 results References 0